Background. Leshmaniasis still represents a reason of public concern worldwide. In Italy, according to epidemiological data, are diagnosed 80 cases of Visceral Leishmaniasis (VL) and 100 of Cutaneous Leishmaniasis (CL) per year. The areas historically interested by parasite circulation are islands, southern regions and the coasts. In Emilia-Romagna, a region of northern Italy, 6.5 cases/year of VL and 3 cases/year of CL have been diagnosed from 2008 to 2012. An increasing number of cases has been registered in 2013, with 30 cases of VL and 9 of CL. The geographical areas involved were Ravenna and Rimini but also the hinterland (Imola, Modena, Bologna). According to the spread of Leishmania infantum (Li) circulation in these areas, aim of our study was to assess the level of subclinical infection (circulant DNA) in patients affected by chronic inflammatory rheumatism (CIR), treated with biologic drugs (BD) and as a consequence, more vulnerable to this parasitosis; second purpose was to correlate the positivity for Li DNA to the area of residence. Materials/Methods. We retrospectively analyzed DNA extracted from PBMC of patients affected by rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, treated with BD for at least 5 years. Each sample has been tested with a qualitative PCR for Li in Infectious Diseases Unit of the University of Ferrara; the positive samples were then tested with a qPCR in the Parasitology Laboratory of the University of Nice, France. The statistical analysis has been performed with the Chi Square Test. Results. Among the 50 analyzed samples, 18 resulted positive (36%) and 1 doubtful (2%) with a qualitative PCR; qPCR confirmed all the results, detecting a high parasite burden (1 to 136 parasite/ml in 4 patients, 1.000 to 40.000 parasite/ml in 11 patients and over 1.000.000 in 3 patients). The doubtful sample resulted to be unequivocally negative. All the analyzed patients had a CD4/CD8 ratio >1.5; 14/18 patients lived in rural areas (77,7%), while 4 (22.3%) in urban areas. Among the 32 patients negative for Li DNA, 8 of them resided in rural areas (25%) and 24 in urban areas (75%) (p≤0.0003). The provinces with the highest incidences were Ravenna (7 cases), Imola (6 cases), Rovigo (3 cases) and Ferrara (2 cases). Conclusion. qPCR performed on PBMC gave higher DNA detection rates than the ones obtained on whole blood in asymptomatic patients. This may be attributable to the reason that i) PBMC are target cells for Li or ii) to the mechanism of action of BD, capable of disrupting parasitic infection (? brutto) control in these patients. According to our knowledge, reports of Li qPCR on DNA extracted from PBMC on particular subset of CIR receiving BD are lacking. These should be further investigated to study the kinetics of parasitic infection.

A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs.

MARITATI, Martina;HANAU, Stefania;BELLINI, Tiziana;DALLOCCHIO, Franco Pasquale Filippo;BONAZZA, Sara;GOVONI, Marcello;CONTINI, Carlo;MASSE', Michel Gaston;HAGO ALMUGADAM, Shawgi Yousif
2016

Abstract

Background. Leshmaniasis still represents a reason of public concern worldwide. In Italy, according to epidemiological data, are diagnosed 80 cases of Visceral Leishmaniasis (VL) and 100 of Cutaneous Leishmaniasis (CL) per year. The areas historically interested by parasite circulation are islands, southern regions and the coasts. In Emilia-Romagna, a region of northern Italy, 6.5 cases/year of VL and 3 cases/year of CL have been diagnosed from 2008 to 2012. An increasing number of cases has been registered in 2013, with 30 cases of VL and 9 of CL. The geographical areas involved were Ravenna and Rimini but also the hinterland (Imola, Modena, Bologna). According to the spread of Leishmania infantum (Li) circulation in these areas, aim of our study was to assess the level of subclinical infection (circulant DNA) in patients affected by chronic inflammatory rheumatism (CIR), treated with biologic drugs (BD) and as a consequence, more vulnerable to this parasitosis; second purpose was to correlate the positivity for Li DNA to the area of residence. Materials/Methods. We retrospectively analyzed DNA extracted from PBMC of patients affected by rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, treated with BD for at least 5 years. Each sample has been tested with a qualitative PCR for Li in Infectious Diseases Unit of the University of Ferrara; the positive samples were then tested with a qPCR in the Parasitology Laboratory of the University of Nice, France. The statistical analysis has been performed with the Chi Square Test. Results. Among the 50 analyzed samples, 18 resulted positive (36%) and 1 doubtful (2%) with a qualitative PCR; qPCR confirmed all the results, detecting a high parasite burden (1 to 136 parasite/ml in 4 patients, 1.000 to 40.000 parasite/ml in 11 patients and over 1.000.000 in 3 patients). The doubtful sample resulted to be unequivocally negative. All the analyzed patients had a CD4/CD8 ratio >1.5; 14/18 patients lived in rural areas (77,7%), while 4 (22.3%) in urban areas. Among the 32 patients negative for Li DNA, 8 of them resided in rural areas (25%) and 24 in urban areas (75%) (p≤0.0003). The provinces with the highest incidences were Ravenna (7 cases), Imola (6 cases), Rovigo (3 cases) and Ferrara (2 cases). Conclusion. qPCR performed on PBMC gave higher DNA detection rates than the ones obtained on whole blood in asymptomatic patients. This may be attributable to the reason that i) PBMC are target cells for Li or ii) to the mechanism of action of BD, capable of disrupting parasitic infection (? brutto) control in these patients. According to our knowledge, reports of Li qPCR on DNA extracted from PBMC on particular subset of CIR receiving BD are lacking. These should be further investigated to study the kinetics of parasitic infection.
2016
Real-Time PCR, Leishmania infantum, parasite DNA , PBMC, Immunocompetent Patients , Chronic Inflammatory Rheumatisms, Rural Areas , screening opportunistic infections, prevention Northern Italy, Biologic Drugs, Emilia Romagna
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2342869
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact